Transactions

Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist program in cancer immunotherapy

Show more

Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling pathways of GPCRs across multiple diseases

Show more
€2.25M EOS imaging

PKvitality announces the signature of a key partnership with Beurer Gmbh

Sector
Series A with German Investor
Show more
$22M EOS imaging

ACTICOR BIOTECH RAISES €7M IN ADDITION TO ITS SERIES B FINANCING, NOW COMPLETED AT €22,3M

Sector
Series B
Show more
€2,5M EOS imaging

TRANSCURE BIOSERVICES RAISES €2,5M FUNDING

Sector
Private Funding Led by Financière Arbevel
Show more
€15M EOS imaging

ACTICOR BIOTECH RAISES €15.3M IN A SERIES B FINANCING

Show more
Load more